Current status and future directions of disease modifying therapy in multiple sclerosis

被引：0
作者：
Segal, Benjamin M. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 245卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
212-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Current and future disease-modifying therapies in multiple sclerosis
    Lim, S. Y.
    Constantinescu, C. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 637 - 650
  • [2] Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions
    Cho, Yongsik
    Jeong, Sumin
    Kim, Hyeonkyeong
    Kang, Donghyun
    Lee, Jeeyeon
    Kang, Seung-Baik
    Kim, Jin-Hong
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2021, 53 (11) : 1689 - 1696
  • [3] Disease-modifying drugs for multiple sclerosis: current and future aspects
    Freedman, Mark S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 : S1 - S10
  • [4] A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
    D'Amico, Emanuele
    Patti, Francesco
    Zanghi, Aurora
    Zappia, Mario
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (10)
  • [5] Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions
    Yongsik Cho
    Sumin Jeong
    Hyeonkyeong Kim
    Donghyun Kang
    Jeeyeon Lee
    Seung-Baik Kang
    Jin-Hong Kim
    Experimental & Molecular Medicine, 2021, 53 : 1689 - 1696
  • [6] Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics
    Rudick, RA
    ARCHIVES OF NEUROLOGY, 1999, 56 (09) : 1079 - 1084
  • [7] Cell therapy for heart disease: current status and future directions
    Kahlon, Arunpreet
    Vaidya, Gaurang
    Bolli, Roberto
    MINERVA CARDIOANGIOLOGICA, 2018, 66 (03): : 273 - 291
  • [8] Antiplatelet therapy in cardiovascular disease: Current status and future directions
    Passacquale, Gabriella
    Sharma, Pankaj
    Perera, Divaka
    Ferro, Albert
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2686 - 2699
  • [9] DNA-based vaccines for multiple sclerosis: Current status and future directions
    Fissolo, Nicolas
    Montalban, Xavier
    Comabella, Manuel
    CLINICAL IMMUNOLOGY, 2012, 142 (01) : 76 - 83
  • [10] Back to the future for multiple sclerosis therapy: focus on current and emerging disease-modifying therapeutic strategies
    Croxford, J. Ludovic
    Yamamura, Takashi
    IMMUNOTHERAPY, 2009, 1 (03) : 403 - 423
12345